Gastrointestinal muscle from man and laboratory animals often responds to low concentrations of kinins and prostaglandins, and the ensuing contraction or relaxation is used by pharmacologists for the detection and assay of these substances. To the gastroenterologist this sensitivity has a different meaning: kinins and prostaglandins might play a physiological or a pathological role in gut motility.
Kinins
The kinin most studied is bradykinin, but comparative studies indicate that the effects of other kinins are qualitatively similar. Bradykinin usually causes contraction of the isolated longitudinal muscle of the gut in many species, but there may be regional variations in response and the circular muscle layer may respond differently from the longitudinal muscle (Rocha e Silva et al. 1949 , Elliott et al. 1960 , Brownlee & Harry 1963 . This is seen clearly in the human isolated intestine (Fishlock 1966) . The longitudinal muscle of the jejunum and ileum is contracted by low concentrations (less than 1 ng/ml) of bradykinin but in the distal half of the human colon it is relaxed by low concentrations of the kinin and gives a biphasic response or a contraction with higher doses. In contrast, the circular muscle of the jejunum is usually insensitive to bradykinin, but the circular muscle of the ileum and colon respond with relaxation. Whether these variations in effect bear any relationship to the normal or abnormal function of gut is not known, but they emphasize that gut muscle is not a single entity.
The only part of the human gastrointestinal tract studied in vivo in response to bradykinin is the distal colon. Murrel & Deller (1967) found that intravenous infusion of bradykinin (10-20 ,ug/min) usually inhibited colonic motility. This finding is consistent with the inhibitory effect of the kinin on the longitudinal and circular muscle seen with small doses in vitro.
The question arises whether kinins play a role in gut motility. A normal role seems unlikely: although an enzyme for forming kinin is present in the gut wall, there is no evidence that kinin precursor is present except in the blood and tissue fluids (Schachter 1969) . But if kinins are involved in controlling the blood supply to the gut, as has been suggested in other tissues, changes in motility might occur under normal conditions as a result of the altered blood flow. In contrast, a pathological role for kinin in some instances of disturbed gut motility does seem feasible. Abnormal levels of bradykinin have been detected in the bloodstream during carcinoid flushes (Oates et al. 1964 ) and during the dumping syndrome (Zeitlin & Smith 1966) , and in view of the high sensitivity of some regions of the human alimentary tract bradykinin might contribute to the accompanying symptoms of borborygmi and diarrhoea. In addition, bradykinin released when the gut wall is inflamed might also affect muscle activity.
Prostaglandins
Prostaglandins of the E and F type, like the kinins, often affect isolated gastrointestinal smooth muscle in low concentrations, and usually have different effects on the longitudinal and circular muscle layers. Prostaglandins of the A and B series are less active. Unlike the kinins, prostaglandins occur naturally in the gut wall and may therefore be involved in normal motor activity of the gastrointestinal tract. Furthermore, prostaglandins are released during peristalsis (Bennett et al. 1967 , Coceani et al. 1967 .
Studies on isolated tissues have shown that in general the F prostaglandins cause contraction of both the longitudinal and the circular muscle of human, guinea-pig and rat intestinal muscle. The E compounds generally have an opposite effect on the two muscle layers: the longitudinal is contracted whereas the circular layer is inhibited (Bennett, Eley & Scholes 1968a , Fleshler & Bennett 1969 ). The different actions of E and F prostaglandins, both of which occur in guinea-pig ileum (Ambache et al. 1966) , are also seen in studies of peristaltic activity in guinea-pig ileum and colon. Whereas PGE1 and PGE2 inhibit the peristaltic activity of the circular muscle, PGFia and PGF2a increase it (Bennett, Eley & Scholes 1968b, Bennett, Eley & Pratt, personal communication) .
The work with isolated gut from man and laboratory animals is clearly consistent with the possibility that prostaglandins are involved in gastrointestinal motility, but only a little is known about their effects in vivo. E prostaglandins injected intra-arterially (approx. I ,ug/kg) cause contraction of the longitudinal muscle of the rat ileum and increase the intraluminal pressure; a similar effect occurs in the colon at a higher dose. The effect of E compounds on the length and intraluminal pressure of guinea-pig ileum is variable, perhaps because of vascular changes caused by the prostaglandins. Even less is known about F compounds on the gut in vivo. So far it has been shown only that they increase guinea-pig colonic pressures when injected intra-arterially at the high dose ofapproximately 100 ,ug/kg (Bennett, Eley & Scholes 1968b , and unpublished observations).
Evidence for an effect of prostaglandin on intestinal motility in man is that intravenous infusion of PGE1 causes abdominal cramps (Bergstrom et al. 1959 ). In addition, oral administration of 0-8-3-2 mg results, after a delay of up to several hours, in loose watery stools, due to increased intestinal propulsion (Horton et al. 1968 , Misiewicz et al. 1969 ). However, it is not known whether the effect of the injected PGE, is caused by the parent compound or by a metabolite acting locally on the bowel wall or after absorption, nor has the possibility of an action on water absorption or some other factor which might influence the gut been excluded.
The present status of prostaglandin with regard to gut motility is that release of these substances within the gut wall might play a local role in controlling muscle activity, and that the effect obtained would depend on which prostaglandin is involved. It seems unlikely that prostaglandins are hormones normally circulated in the bloodstream to control gastrointestinal activity, because many are potent vasoactive substances and are rapidly metabolized in the lungs and liver (Ferreira & Vane 1967) . On the other hand, a pathological role for circulating prostaglandins seems possible, since they are sometimes released into the bloodstream from certain tumours in patients who have associated diarrhoea (Williams etal. 1968 ).
Finally, another aspect of prostaglandin action on the gut which deserves special mention is the ability of E and A prostaglandins to inhibit gastric secretion. This was first demonstrated with parenterally administered E-type compounds in conscious dogs whose gastric secretion was stimulated with food or histamine (Robert et al. 1967 ), but the possibility that the inhibition was secondary to vascular effects or changes in gut motility cannot be ruled out. Perfusion of prostaglandin E1 through the gastric lumen in anesthetized rats also inhibits secretion (Ramwell & Shaw 1968 ). This seems likely to be a specific effect on the secretory mechanism since no hypotension occurs (Bennett & Hogbin, personal communication) , but even so it is not possible to exclude local hamodynamic or muscle effects. Only in isolated bullfrog gastric mucosa is it clear that inhibition of gastric secretion is not due to vascular changes or to alteration of muscle contractility (Way & Durbin 1969) . The only secretion study in man has been with orally administered doses of PGE1 which resulted in concentrations of at least 13-50 ,ug/ml during part of the experiment (Horton et al. 1968 ). There was no reduction in the pentagastrininduced acid secretion, and indeed secretion may even have increased. Whether an inhibition occurs under different conditions or with PGES which is the naturally occurring prostaglandin in human gastric mucosa (Bennett, Murray & Wyllie 1968) remains to be determined. The answer to this question may be of clinical importance: prostaglandin might act as a feedback mechanism to limit gastric secretion (Horton 1969) , and it follows that derangement of such a mechanism could result in hypersecretion.
Summary
Kinins affect gut muscle in low concentrations, but they seem unlikely to play a normal role in gut motility since there is no evidence that kinin precursors occur within the gut wall. Bradykinin levels in the blood are elevated in the carcinoid and dumping syndromes, and might account in part for accompanying disturbances of gut motility.
Prostaglandins occur within the gut wall, and might play a normal role in gastrointestinal motility since they affect the muscle in low concentrations. The effect on the gut would depend on which prostaglandin is involved. Prostaglandins are released into the bloodstream from certain tumours and might play a part in the accompanying diarrhoea. Prostaglandins of the E and A series inhibit gastric secretion in laboratory animals but no such effect has yet been demonstrated in man.
